Trial intelligence / Profile preview

Remimazolam vs propofol for sedation in painless colorectal polypectomy

ChiCTR2600125283Phase 4Not yet recruiting

Sponsor
The First People's Hospital of Longquanyi District, Chengdu
Start
May 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in intestinal polyp comparing Remimazolam + alfentanil with Propofol + alfentanil (2 arms). Primary endpoints: Peripheral oxygen saturation (SpO2) and Mean arterial pressure. Planned start May 2026; status: not yet recruiting.

02

Drugs

remimazolampropofol
03

Conditions

intestinal polyp

Beyond the preview

Go deeper on ChiCTR2600125283.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600125283.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call